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Abstract
Background: Tuberculosis (TB) is a major public health concern in South Africa and TB-related mortality remains
unacceptably high. Numerous clinical studies have examined the direct causes of TB-related mortality, but its wider,
systemic drivers are less well understood. Applying systems thinking, we aimed to identify factors underlying TB
mortality in South Africa and describe their relationships. At a meeting organised by the ‘Optimising TB Treatment
Outcomes’ task team of the National TB Think Tank, we drew on the wide expertise of attendees to identify factors
underlying TB mortality in South Africa. We generated a causal loop diagram to illustrate how these factors relate to
each other.
Results: Meeting attendees identified nine key variables: three ‘drivers’ (adequacy & availability of tools, implementation of
guidelines, and the burden of bureaucracy); three ‘links’ (integration of health services, integration of data systems, and
utilisation of prevention strategies); and three ‘outcomes’ (accessibility of services, patient empowerment, and socio-
economic status). Through the development and refinement of the causal loop diagram, additional explanatory and linking
variables were added and three important reinforcing loops identified. Loop 1, ‘Leadership and management for outcomes’
illustrated that poor leadership led to increased bureaucracy and reduced the accessibility of TB services, which increased TB-
related mortality and reinforced poor leadership through patient empowerment. Loop 2, ‘Prevention and structural
determinants’ describes the complex reinforcing loop between socio-economic status, patient empowerment, the poor
uptake of TB and HIV prevention strategies and increasing TB mortality. Loop 3, ‘System capacity’ describes how fragmented
leadership and limited resources compromise the workforce and the performance and accessibility of TB services, and how
this negatively affects the demand for higher levels of stewardship.
Conclusions: Strengthening leadership, reducing bureaucracy, improving integration across all levels of the system,
increasing health care worker support, and using windows of opportunity to target points of leverage within the South
African health system are needed to both strengthen the system and reduce TB mortality. Further refinement of this
model may allow for the identification of additional areas of intervention.
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Introduction
In 2019, an estimated 360,000 people developed tubercu-
losis (TB) in South Africa; 58 % of these individuals were
HIV positive, and 17 % died [1]. According to death certif-
icates, TB remains South Africa’s leading natural cause of
death [2], highest in HIV-positive people (particularly
those admitted to hospital [3]), in whom it is often undiag-
nosed [4]. Morbidity and mortality after completion of an-
tituberculosis treatment is also increasingly recognised as
an important outcome [5] with individuals who ‘success-
fully’ complete TB treatment having a four-fold increase
in mortality compared to the general population [6, 7].
Health systems are non-linear and are best thought of as
complex adaptive systems, in which the many interacting
parts make it near impossible to predict the behaviour of a
system based only on the knowledge of its components
[8]. The South African health system has undergone sig-
nificant change over the past 26 years. Much has been
written about the transition of health services after the
end of apartheid and the importance of a freely elected
government in driving health system reform [9]. From
1994, South Africa embarked on a series of strategies to
reform primary health care (PHC) through orienting to-
wards population health; focusing on health outcomes;
developing integrated, efficient PHC teams guided by
communities; establishing a district health system; and
paying closer attention to the social determinants of
health. [10] However, the effectiveness and quality of the
health services remain sub-optimal, and health outcomes
remain poor. Four colliding epidemics, including HIV and
TB, and the corresponding disease burden in South Africa
were well described in 2012 [11]. The public and private
health sectors in South Africa have been described as
‘pro-rich’ although the poor bear the greater burden of ill-
health (up to 13-fold increased incidence of TB) and have
access to far fewer services compared to the rich [12]. A
2012 review identified differentials in social determinants
of health, the need for comprehensive integration of all as-
pects of the South African health system, and improved
surveillance and information systems as “core needs” [11]
for the transformation of the South African health system.
Previous health system analyses of TB in South Africa
have focussed on TB and HIV collaborative activities at
facility level [13] as well as delays in diagnosis and treat-
ment of TB patients [14]. Barriers to implementation of
collaborative activities that have been identified included
insufficient consultative leadership and political will; or-
ganisational culture; management, planning and power
issues; unequal financing; and human resource capacity
[13]. Factors associated with patient and health care sys-
tem delays in diagnosis and treatment of TB included
accessibility; staff skills and training; specimen and test-
ing logistics; and the role of traditional healers [14]. Glo-
bally, weak health systems have been shown to impact
on the performance of the TB care cascade[15] and calls
have been made for monitoring beyond routine TB
programme indicators to include the quality of TB care
including clinical competence; timely, continuous, and
integrated care; and respectful and patient-centered care
[16]. However, while numerous studies have examined
direct and clinical causes of TB-related mortality, health
systems analyses have not been undertaken to explore
the wider, systemic drivers of TB mortality. Using a
series of systems tools, we aimed to identify factors
underlying TB mortality in South Africa and describe
how these factors relate to each other.
Methods
Context
South Africa is a high tuberculosis (TB) burden country
[1] and has the largest HIV epidemic and antiretroviral
therapy (ART) programme in the world [17]. The ‘front
line’ of the South African health system is the almost 3,
500 PHC clinics where a range of services are offered [18],
including diagnosis and treatment for TB and HIV. TB
diagnosis is currently largely reliant on passive case find-
ing, where individuals presenting at PHC clinics are
screened using the World Health Organization (WHO)
four-symptom screen and sputum is evaluated using
Xpert MTB/RIF (Xpert; Cepheid, Sunnyvale, CA). PHC
facilities are grouped into a sub-district, and multiple sub-
districts form a health district which is the level at which
PHC services are managed. Across the 52 health districts
of South Africa, the population density, demographics,
and health outcomes vary [19]. Importantly the 2017
death rate during drug-susceptible TB treatment varied
significantly across the districts from a low of 2.6 % to a
high of 15.1 %; 9/52 districts had a death rate > 10 %; 8/52
had a death rate ≤ 5 % (including all 6 districts in the
Western Cape Province); and 21/52 districts showed a de-
crease in death rate from 2016 to 2017 [19]. If an individ-
ual requires additional investigations and diagnosis, they
will be referred from a PHC clinic to a district, secondary
or tertiary level hospital. Hospitals may initiate TB and
HIV treatment, but patients are then down-referred to
PHC clinics for the continuation and completion of TB
treatment. TB and HIV integration activities in South
Africa have progressively been implemented and include
testing all TB patients for HIV; screening all HIV-positive
people for TB; and providing TB preventive therapy
(TPT) to those who are eligible [20]. In South Africa, 93 %
of TB testing in 2012 was conducted in the public sector
at the National Health Laboratory Services [21] and, in the
2018 South African TB prevalence survey, 92 % of people
with TB first accessed care in the public sector [22]. Al-
most all people diagnosed with TB are treated in the pub-
lic sector with 3 % of TB medication in South Africa used
in the private sector [23].
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South African TB think Tank
The South African National Department of Health
established the TB Think Tank in 2014, drawing on na-
tional expertise, research capacity, and international net-
works, to support evidence-informed decision making,
and was successful in supporting the first TB/HIV in-
vestment case for TB in South Africa [24]. The Think
Tank has six task teams; in early 2020, the ‘Optimising
TB Treatment Outcomes’ task team convened a meeting
in Cape Town, South Africa, with 47 attendees included
academics, clinicians, representatives of non-profit orga-
nisations, TB advocates, and TB programme officials
(national, provincial, and district level). All members of
the TB Think Tank were invited to submit abstracts on
TB-mortality related studies which had recently been
completed or were currently underway in South Africa
at the time of the seminar. Abstracts were reviewed by
three independent reviewers and scored according to
whether: 1) the title reflected the study; 2) the study
question was clear; 3) the methods were appropriate for
answering the study question; 4) the results answered
the study question; and 5) the discussion and conclusion
were appropriate and suggested a way forward. In
addition, to ensure diversity of perspectives, presenta-
tions from TB programme managers and implementing
partners were included even if not scored as highly as
those of academics.
Systems Thinking
As described in more detail below, we used a systems
thinking approach to identify factors underlying TB
mortality in South Africa by: (i) understanding the con-
text; (ii) using root cause analysis by individuals; (iii)
group work to establish themes and consider relation-
ships; and (iv) refinement of relationships and causal
loop model development using a small core group.
Systems thinking provides the opportunity to understand,
test, and revise our understanding of how the different com-
ponents in a system work together and is increasingly used in
public health [25]. TB mortality in South Africa was contex-
tualised at this seminar through research-based oral and pos-
ter presentations. Attendees from the TB Think Tank
included academics, TB programme managers, and non-
governmental organisations, providing a diverse group at the
workshop. Following the presentations, a facilitated discussion
was conducted using four small groups. Workshop partici-
pants were allocated at random to groups and one workshop
facilitator ensured diversity within each small group.
Systems thinking tools were described and facilita-
tors for each group were available to assist with the
implementation of activities. Each meeting attendee
was asked to use the fish bone analysis and/or the
“five whys” technique to identify the underlying health
system reasons [26] why people in South Africa are
dying of TB. Results were recorded on post-it notes
and, after exhaustion of ideas, individuals worked in
groups to produce affinity diagrams by organizing the
post-it notes into logical groupings to identify stra-
tegic themes, [27] (referred to henceforth as key vari-
ables). Each group worked independently and
identified 9–13 key variables which represented the
underlying causes of TB mortality in South Africa. To
challenge pre-existing mental models, groups then
discussed relationships between each key variable and
produced a visual representation of interactions be-
tween key variables (an interrelationship diagraph)
using arrows to depict the ‘direction’ of each relation-
ship [28].
Following the meeting, the authors reviewed the key
variables in each group’s affinity diagram and interrela-
tionship diagraph and undertook a series of meetings to
aggregate the key-variables and document the relation-
ships described. Based on the direction of the relationships
in the interrelationship diagraphs, each key variable was
assigned a score, which denoted the number of arrows
moving towards and away from it. Drivers were those
variables with the most arrows pointing away from them,
outcomes had the most arrows pointing to them, and links
had an equal number of arrows in and out [28]. A prelim-
inary causal loop diagram (CLD) was developed to illus-
trate the causes of TB mortality in South Africa. By
tracing the relationship between each variable in the CLD,
the direction of change was described as the “same” or
“opposite” and the effect of one part of the system on the
remaining variables was then traced through each loop
[28]. Loops can be classified as reinforcing or balancing. In
a reinforcing loop, change in one variable results in the
same change across the system and, eventually, has the
same effect on the initial variable, perpetuating either an
increase or decrease in the system overall [28]. In contrast,
a balancing loop generates equilibrium: change in one
variable results, eventually, in the opposite effect being
exerted on the same variable following the effect across
the system [28]. In a balancing loop an increase in one
variable results in an eventual decrease in the same vari-
able, producing a balanced state with no change. Through
an iterative process the authors developed and refined the
CLD using Vensim PLE for Windows Version 8.1 (https://
vensim.com/).
Ethics
This article reports the outcomes of a meeting of the
National TB Think Tank mortality task team. As there
were no human research participants, no formal inter-
views conducted, and data collected were not attributed
to individuals, ethical approval was not sought. Opinions
or viewpoints have not been attributed to specific
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individuals or groups of individuals and no identifiable
details of meeting attendees are included.
Results
Nine key variables relating to TB-related mortality in
South Africa were identified; three key drivers: adequacy
and availability of tools, implementation of guidelines, and
burden of bureaucracy; three links: integration of health
services, integration of data systems, and utilisation of pre-
vention strategies; and three outcomes: accessibility of ser-
vices, patient empowerment, and socio-economic status
(Fig. 1). Through the iterative process of developing the
CLD, four further explanatory variables were added: work-
force; resources and financing; leadership and governance;
and competing priorities. These were included in the CLD
and provided clarity on the mechanisms through which
the key variables interacted (Fig. 2).
Drivers
The adequacy and availability of the latest tools for TB
screening, investigation, prevention, diagnosis, treatment,
and adherence were discussed. Appropriate guidelines and
algorithms for the comprehensive management of TB
were widely recognised as important to reduce mortality,
but gaps in implementation, quality of services, and evalu-
ation of policies were identified as contributing to mortal-
ity. In addition, limited support for the implementation of
guidelines for complex disease, comorbidities and drug re-
sistant TB were also highlighted. The significant number
of administrative procedures associated with TB manage-
ment, which, ironically, compromises the quality of care it
seeks to safeguard, was labelled as the burden of
bureaucracy.
Links
Multiple components of service integration were de-
scribed: the lack of public and private health service in-
tegration for TB testing and treatment; poor referral
pathways between different levels of care, facilities, and
districts; poor integration of TB into different pro-
grammes such as HIV, reproductive health, and non-
communicable diseases; and the inability of the system
to provide a TB patient access to all these services dur-
ing a single visit. The failures of TB data systems to
communicate, exchange data, and use health and related
data in a timely manner were identified as contributing
to TB related mortality. The inability to ascertain results,
treatment history, and outcomes of patients regardless
of place or time of management was highlighted, with
the assertion that poor intersectoral integration and lack
of data sharing between health, social and correctional
services further undermines efforts to comprehensively
manage TB patients. The failures of the optimal use of
proven TB prevention strategies also contributed to TB
Fig. 1 Interrelationship diagraph of key variables underlying TB mortality in South Africa, depicting drivers, links and outcomes. I: in; O: out; TB: tuberculosis
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related mortality including the coverage of bacille
Calmette-Guérin (BCG) immunisation at birth (and the
lack of effective alternatives more than a century after its
development); poor tracing, screening, and follow-up of
contacts; neglect of infection prevention and control
(IPC) measures in public and healthcare settings; and
failures in the provision and uptake of TPT. Given the
important role of ART in reducing TB-associated mor-
bidity and mortality in people with HIV, strategies to
prevent and treat HIV were also considered TB preven-
tion strategies.
Outcomes
Limitations to accessibility of services included availabil-
ity, affordability, and acceptability of TB services [29,
30]. This definition of access has been presented previ-
ously and allows consideration of true access rather than
coverage of health services as a proxy for access [30].
Availability (physical access) referred to services being
available to meet the needs of the population and in-
cluded geographical location, operating hours, and actual
services supplied. Affordability (financial access) referred
to the full costs to the health service user, including
transport costs and loss of income whilst travelling to
and utilizing the health service. Acceptability referred to
expectations of the health system user, health care
worker (HCW) attitudes, waiting times, and the way the
service is organized (as experienced by the patient). Earl-
ier work reported that the greatest deficiency in access
to health services in South Africa was availability: con-
straints of affordability related mostly to travel costs,
while acceptability levels were high, at 90 % [31]. Import-
antly, rural households and vulnerable populations,
including those who were less educated, poor, and un-
employed tended to be less likely to have adequate
access [31]. While health service acceptability has gener-
ally been high in South Africa [31], at our workshop,
attendees described TB preventive therapy as a strategy
that was perceived as unacceptable in many communi-
ties. Specific strategies, including TB prevention, need to
be evaluated for acceptance across the diverse cultures
in South Africa. The lack of patient empowerment
Fig. 2 Causal loop diagram describing factors affecting TB mortality in South Africa, developed through group process. O: opposite; R: reinforcing; S:
same; TB: tuberculosis. Variables in black reflect the key variables identified and variables in grey reflect additional explanatory variables that were
added. Three colours were used to differentiate the reinforcing loops discussed in this paper, orange: Loop1; blue: Loop 2; purple: Loop 3
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included the way patients understood their role and the
limited knowledge and skills patients were given by their
health care providers. This disempowerment is further
entrenched by a health system which fails to recognize
community and cultural differences or encourage patient
participation. We also considered patient empowerment
to include TB-related stigma and the ability of individ-
uals to manage the additional burden that stigma added
to their lives. The overall socio-economic status of indi-
viduals with TB was identified as an underlying cause of
death among people with TB in South Africa. This de-
termines patients’ access to resources (primarily financial
resources, but also educational, as well as well-struc-
tured and ventilated housing, opportunities for em-
ployment, transport, and security); vulnerability and
exposure to substance abuse; and appropriate add-
itional support (nutritional, mental health services, or
social care).
Workforce; resources and financing; leadership and
governance; and competing priorities were additional ex-
planatory variables thought to have an important impact
on mortality through interactions with other elements.
Workforce included staff capacity, attitude, and burnout.
Resources and financing referred to how funds are allo-
cated, managed, and spent at national, provincial,
district, sub-district, and facility levels; the processes for
motivating for additional funds; and how funding was
re-allocated. Effective leadership and governance across
every level is required and we considered the importance
of different leadership styles. Transactional leadership
has been considered to be the most prevalent model in
existing health systems [32, 33] and requires those in
leadership positions to effectively plan, implement,
monitor activities and reward employees [32, 33]. Adap-
tive leadership is used to enable groups of people to
overcome change, and the adaptive leader typically does
not focus on the technical solution but rather the
process of collaboration to overcome old values and be-
liefs empowering teams to develop their own solutions
[32, 33]. Transformational leaders inspire teams to look
beyond individual motivations and work towards the or-
ganisational mission but are dependent on the vision
and values of the leader [33]. Earlier work has argued
that servant leadership is the ideal within health systems
as the leader remains focused on the needs of others,
both healthcare workers and patients [33]. The servant
leader uses the strength of the team to develop trust and
core moral and ethical beliefs to effect changes and im-
prove the value of care that is delivered by the health
system [33]. The greatest limitation with all these
models of leadership is the reliance on an individual as a
leader. Participatory leadership built on the value of
multiple perspectives and diverse strength embodies col-
lective decision making to effect change across the
health system and includes ‘interactive’, ‘collective’, ‘con-
sultative’, ‘distributed’ and ‘horizontal’ leadership [34]. A
recent series on health leadership in Africa showed the
negative impact of existing leadership styles and the po-
tential for change using new forms of participatory lead-
ership which values the role of health system actors and
enables greater participation in leadership [35]. Compet-
ing priorities included urgent or emergent conditions
that have undermined TB service delivery across all
levels of the health system, with multiple programmes
competing for limited resources.
Causal loop diagram
A causal loop diagram was constructed to illustrate the
relationships between the key variables and TB mortal-
ity; three distinct reinforcing loops were described
(Fig. 2). Loop 1, ‘Leadership and management for out-
comes’, is a reinforcing loop from leadership through to
TB services and mortality. Loop 2, ‘Prevention and struc-
tural determinants’ is a reinforcing loop affecting TB
mortality, including the utilisation of TB prevention
strategies, patient empowerment, and socio-economic
status. Loop 3, ‘System capacity’ includes the role of
leadership and the workforce in improving the accessi-
bility of services and the implementation of TB preven-
tion strategies. In loop 3, the effect of the use of
prevention strategies on patient empowerment and lead-
ership completes this reinforcing loop, where we expect
empowered patients will contribute to improved leader-
ship through elements of participatory leadership.
Discussion
Using an iterative process, a series of systems thinking
tools, and drawing on a wide range of experience, we
have presented a conceptual model of TB mortality
within the complex South African health system. This
provides an opportunity to consider the key variables,
their interactions, and the points of leverage for inter-
vention to reduce TB mortality.
Loop 1: Leadership and management for outcomes
This vicious cycle runs from poor leadership, through the
burden of bureaucracy, to reduced accessibility of TB ser-
vices, which worsens outcomes (TB-related mortality) and
therefore worsens leadership through negative reinforcement.
Several studies have documented the impact of health sys-
tems performance on treatment outcomes with an increased
likelihood of unsuccessful health outcomes when health sys-
tems are dysfunctional [36, 37]. A 2012 review recognised
the new political leadership in South Africa since 1994 and
the proactive policy changes, but these were undermined by
managerial bureaucracy [11]. The National TB treatment
guidelines call for a sensitive and supportive approach to pa-
tients’ needs, but still specifically include directly observed
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treatment, which requires a treatment supporter to watch
the patient swallowing tablets [38]. The legacy of the TB
programme and bureaucratic delays and resistance to change
have meant that the decisions made at various levels of the
health system lead to failures in implementation of appropri-
ate and available TB management guidelines, poor use of
available tools, and limited access to TB services, which con-
tribute to delayed diagnosis, sub-optimal treatment, poor TB
treatment outcomes, and increases in TB-related mortality
[39, 40]. Barriers to access also undermine efficacious treat-
ment and failing to complete treatment can lead to drug-
resistant disease [41–43], which has worse outcomes [44]
and high mortality rates [45]. Supportive supervision and ac-
countability [37], together with the availability and imple-
mentation of guidelines and protocols [46, 47] improve
quality of care and health system performance, thereby redu-
cing TB mortality and disease burden [37, 46, 47]. An oppor-
tunity exists for improving leadership in South Africa.
Participatory leadership can be used to facilitate collaborative
work to empower teams to develop efforts to reduce the bur-
den of bureaucracy and to take actions to convert loop 1 to a
virtuous cycle, where positive change will perpetuate further
positive change. When considering the historical emphasis
on transactional leadership, participatory leadership can be
used to engage academics, clinical staff and health managers
to jointly set targets for the implementation of changes [33]
within the TB programme. A strength of servant leadership
is its alignment with the values of healthcare workers and
the delivery of patient-centred care [33] and these principles
should be part of participatory leadership.
In the South African context, where almost 60% of
people with TB are HIV positive [48], integration of TB
and HIV services is important to improve accessibility and
reduce barriers to care. [49]. Evidence supports the feasi-
bility, safety, and effectiveness of integration of ART and
TB services, [50], while failing to integrate TB and HIV
services has been shown to increase mortality and poor
treatment outcomes [51, 52]. Greater overall integration is
important for reducing TB mortality, be that integration
between HIV, TB, and noncommunicable disease pro-
grammes [53] or integration across levels of service. Re-
cent cohort studies have highlighted the relationship
between poor follow-up and hospital-readmission and
mortality [54, 55]. Improvements in patient pathways be-
tween PHC facilities and hospital are essential, particularly
for people living with HIV. Public-private collaboration
has been identified as a promising strategy for TB control
globally, but limited projects have been implemented in
South Africa [56] and may reflect a lower priority as the
vast majority of TB is diagnosed and managed in the pub-
lic sector [21–23]. Comprehensively addressing integra-
tion of services has the potential to provide TB patients
with a continuous service at PHC following the in-
hospital diagnosis of TB; a reduced time between
diagnosis and treatment support in a PHC setting; and a
better link of patients to community-based services fol-
lowing a diagnosis of TB.
Loop 2: Prevention and structural determinants
The relationship between TB mortality, socioeconomic
factors, access, and treatment practices has been well
established [57] and in this loop we illustrate the
complex ways socio-economic status relates to TB
mortality through the uptake of routine prevention
strategies and patient empowerment, and how in-
creasing TB mortality further perpetuates inequalities
in socio-economic status. Interventions to address so-
cial and economic factors of individuals have included
small incentives or food support but have not ad-
dressed the underlying health inequalities which drive
the ability to access and sustain successful TB treat-
ment [57]. Interventions to address socioeconomic in-
equities within this loop require intersectoral
collaboration; addressing the social determinants of
health is critical if we are to reduce TB mortality in
South Africa [58]. Prevention strategies, defined as
the range of measures intended to interrupt transmis-
sion and reduce incidence of TB and HIV, have con-
siderable influence on TB mortality by their effect on
the burden of disease in the population, [59] but
socio-economic deprivation affects an individual’s
ability to make use of these prevention strategies. Ad-
dressing the sub-optimal implementation of preven-
tion strategies [60–63] requires a health system-level
approach to improve the uptake of TB prevention
[64] and provide a bridge between guidelines and util-
isation in practice [62, 65]. A window of opportunity
exists as South Africa plans for the roll-out of revised
TB prevention guidelines in early 2021. These guide-
lines aim to expand the eligibility criteria for TB pre-
vention to reach everyone with significant exposure to
TB and offer multiple options for the duration of pre-
ventive therapy from 3 to 12 months. Creating the
appropriate demand and increasing the utilisation of
TB prevention has the potential to improve patient
empowerment as communities are given the oppor-
tunity to engage with TB prevention beyond the nar-
row focus of previously defined at-risk populations
(children under 5 years of age and people living with
HIV). Patient empowerment is a fundamental compo-
nent of participatory leadership [34]. Global and local
responses to HIV including the Treatment Action
Campaign and Section 27 have demonstrated how pa-
tient empowerment and the development of advocacy
groups were used to guide health leaders on treat-
ment policy and the allocation of financial resources
[34]. The opportunity for leveraging the benefits of
participatory leadership in the South African health
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system can be seen in Loop 2 where an increase in
empowered patients could contribute to improved
leadership and governance and generate a virtuous
cycle.
Loop 3: System capacity
‘System capacity’, here, is not restricted only to the abil-
ity of HCWs to provide the best care but rather reflects
the overall health system’s capacity to create and foster
the right conditions for optimal care. We described how
existing poor leadership and limited resources have
compromised both the workforce and the performance
and accessibility of TB services. This negative effect fur-
ther disempowers patients. In South Africa, we have
seen how empowered patients have demanded more
from health leaders. The Treatment Action Campaign
launched in 1998 to campaign for access to HIV treat-
ment achieved a South African Constitutional Court rul-
ing ordering the provision of antiretroviral therapy to
mothers for the prevention of mother to child transmis-
sion of HIV in 2002 [66] and was integral to the expan-
sion of the ART program. Loop 3 suggests through the
strategy of TB prevention there is an opportunity to
develop leaders who are accountable and responsive to
the needs of the people. Earlier work has shown how
newly introduced, additional services are likely to be the
first to be compromised when resources are constrained
and the burden on the workforce is increased [67]. Con-
sideration of HCW capacity provides an opportunity to
increase the numbers of well trained (knowledge and
skills) and motivated staff. HCW capacity-building needs
to move beyond clinical education to include skills for
broader population health management, patient-centred
care, patient counselling, cultural sensitivity, and under-
standing and managing bias and stigma [16]. It is critical
that this takes place across the wider health system, as
people with TB make contact with a range of staff, not
just specialised TB staff in TB services. When combined
with good supervision and support, trained and sup-
ported staff have the distinct advantage of improving
health outcomes for patients [68]. Lessons from Lesotho
have shown how capacity building with training and
support can be used to strengthen the implementation
of a complex health intervention like the management of
multidrug-resistant TB [69]. This contrasts with early
experiences from South Africa, where HCWs experi-
enced the drug-resistant TB programme with fear and
anxiety, having concerns around being unsupported and
the quality of care they could offer [70]. The National
Department of Health should prioritise the ongoing sup-
port and development of HCWs, recognising the critical
place of capacity development of all staff and its poten-
tial to affect TB mortality.
Leadership, resources, the attention of the workforce,
and accessibility of facilities have been compromised in
2020 due to the coronavirus disease (COVID-19) pan-
demic and this has resulted in unprecedented drops in
screening and testing of people with possible TB [71].
Despite this, there are opportunities afforded by the re-
sponse to the pandemic, including respiratory protection
and IPC, that can be positively leveraged for TB. Public-
facing TB dashboards (highlighting contagion and loss
of life in specific geographic areas); communication cam-
paigns; and real-time accountable performance monitor-
ing of TB services, as implemented for COVID-19, may
improve patient empowerment and integration of ser-
vices [72].
Strengths and limitations
The underlying factors identified represent a wide array
of experience in the field of TB in South Africa. The use
of individual brainstorming for generating ideas and
group work for organising the potential key variables
created the opportunity for all attendees to contribute,
drawing on diverse and experienced perspectives. We
have produced a plausible model and provided evidence
for these relations from the published literature. We
were unable to validate our model but propose that fur-
ther health system research could identify opportunities
for intervention and support the development of local
action plans to be implemented and observe the changes
in our model. Previous work using group model building
and a CLD allowed the development of local action
plans by key stakeholders to improve the poor quality of
maternal health services in the Eastern Cape [73]. In
Rwanda, following the national scale-up of integrated
community case management of malaria, pneumonia,
and diarrhoea a health systems study and CLD was used
to identify determinants of sustainability of the interven-
tion and potential risks [74]. This presents the opportun-
ity for future work using our CLD to develop local
action plans for implementation and consider strategies
for mitigating possible future risks as in the preceding
studies described.
Conclusions
We describe underlying health system factors contributing to
TB mortality in South Africa. We have presented a CLD to
illustrate their interactions and describe three important re-
inforcing loops, ‘Leadership and management for outcomes’,
‘Prevention and structural determinants’, and ‘System cap-
acity’. Our analysis highlights the complex drivers and mul-
tiple interactions within both the national TB programme
and the wider health system that contribute to the continued
high levels of TB-related mortality in South Africa. Interven-
tions to address mortality will be of limited effect unless they
are designed and enacted with consideration of the
Osman et al. BMC Health Services Research          (2021) 21:388 Page 8 of 11
constraints and dynamics of the system. Cross-cutting mea-
sures that look to strengthen the overall system include the
call for improvements in leadership with a reduction in bur-
eaucracy in the health system. The aspirational goal of par-
ticipatory leadership has been highlighted as have been the
opportunities to uses some of the strengths of other leader-
ship styles. Additionally, improved integration across all
levels; and a focus on increasing HCW capacity and support
were highlighted. Using windows of opportunity, such as
those presented by COVID-19 or the release of new guide-
lines, open up the possibility of leveraging small efforts to ef-
fect significant change in the health system. Further
refinement of this model may provide additional opportun-
ities to identify points of leverage to reduce TB mortality and
should be evaluated.
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